Details for Patent: 5,985,864

✉ Email this page to a colleague

Summary for Patent: 5,985,864

Scope and claims summary:

Title:	Polymorphs of donepezil hydrochloride and process for production
Abstract:	Donepezil hydrochloride, 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride, is provided here in the form of four polymorphs which are stable against heat and humidity in the pharmaceutical use. They can be industrially produced. They are specified by peaks in X-ray powder diffraction pattern and absorption peaks in infrared absorption spectra in potassium bromide.
Inventor(s):	Imai; Akio (Ibaraki, JP), Watanabe; Hideaki (Ibaraki, JP), Kajima; Takashi (Ibaraki, JP), Ishihama; Yasushi (Ibaraki, JP), Ohtsuka; Akiyo (Ibaraki, JP), Tanaka; Tomohide (Ibaraki, JP), Narabu; Yukio (Ibaraki, JP)
Assignee:	Eisai Co., Ltd. (Tokyo, JP)
Application Number:	08/870,394
Patent Claim Types: see list of patent claims	Compound; Process; Use; Composition;

Drugs Protected by US Patent 5,985,864

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 5,985,864

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	8-146293	Jun 07, 1996

International Family Members for US Patent 5,985,864

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	230396	⤷ Subscribe
Austria	445603	⤷ Subscribe
Australia	1153097	⤷ Subscribe
Australia	2979297	⤷ Subscribe
Australia	731282	⤷ Subscribe
Canada	2252806	⤷ Subscribe
Canada	2516108	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.